Nitric BioTherapeutics Launches Phase II Clinical Trial For The Use Of Nitric Oxide In The Healing Of Chronic Wounds (Lufee.com)

Lufee categories

Nitric BioTherapeutics Launches Phase II Clinical Trial For The Use Of Nitric Oxide In The Healing Of Chronic Wounds
Nitric BioTherapeutics (Nitric Bio) announced the beginning of a Phase II clinical trial for the treatment of chronic wounds using nitric oxide. Affecting between 4.5 and 5 million Americans in the form of diabetic, venous stasis and decubitus ulcers, chronic wounds cost the U.S. healthcare system in excess of $2.5 billion per year and results in significant burden to patients.
- Discuss this news

Tell-a-friend about Lufee and this article

You are not logged in to Lufee at this moment. But you can tell a friend about this headline and send him an e-mail with your personal comment.

You still don't have a Lufee Account?

Sign up now and...

Get your personal account for free and sign up today. The sign up process will take you less than 5 minutes.

Signup here for free

Read what other users has to say

Nobody has posted a comment yet. Be the first to leave feedback on this news.

Read other headlines

New users at Lufee